Regulation mechanism of PDK1 on macrophage metabolism and function

Cell Biochemistry and Function

Volumn 34, Issue 8, 2016, Pages 546-553

  Yang, Yueqin ^a   Kong, Weiwei ^a   Xia, Zhi ^b   Xiao, Lin ^c   Wang, Song ^a  

^a WUHAN SPORTS UNIVERSITY   (China)

^b JINGGANGSHAN UNIVERSITY   (China)

^c ZHAOQING UNIVERSITY   (China)

Author keywords

inflammation; macrophages; migration; PDK1; phagocytosis

Indexed keywords

PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE;

CELL METABOLISM; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; INFLAMMATION; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; BIOLOGICAL MODEL; CELL MOTION; MACROPHAGE; METABOLISM; PATHOLOGY;

CELL MOVEMENT; HUMANS; INFLAMMATION; MACROPHAGES; MODELS, BIOLOGICAL; PHAGOCYTOSIS; PROTEIN-SERINE-THREONINE KINASES;

EID: 85004010385     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3235     Document Type: Review

References (72)

1. Wick KL, Liu F. A new molecular target of insulin action: regulating the pivotal PDK1. Curr Drug Targets Immune, Endocr Metabol Disord. 2001;1:209–221.
2. Alessi DR, James SR, Downes CP, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Current biology : CB. 1997;7:261–269.
3. Stokoe D, Stephens LR, Copeland T, et al. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science. 1997;277:567–570.
4. Mora A, Komander D, van Aalten DM, Alessi DR. PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol. 2004;15:161–170.
5. Bayascas JR. PDK1: the major transducer of PI 3-kinase actions. Curr Top Microbiol Immunol. 2010;346:9–29.
6. Calleja V, Laguerre M, de Las H-MG, Parker PJ, Requejo-Isidro J, Larijani B. Acute regulation of PDK1 by a complex interplay of molecular switches. Biochem Soc Trans. 2014;42:1435–1440.
7. Venigalla RK, McGuire VA, Clarke R, et al. PDK1 regulates VDJ recombination, cell-cycle exit and survival during B-cell development. EMBO J. 2013;32:1008–1022.
8. Lim MA, Kikani CK, Wick MJ, Dong LQ. Nuclear translocation of 3'-phosphoinositide-dependent protein kinase 1 (PDK-1): a potential regulatory mechanism for PDK-1 function. Proc Natl Acad Sci U S A. 2003;100:14006–14011.
9. Kikani CK, Dong LQ, Liu F. “New”-clear functions of PDK1: beyond a master kinase in the cytosol? J Cell Biochem. 2005;96:1157–1162.
10. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci. 2001;26:657–664.
11. Avruch J, Belham C, Weng Q, Hara K, Yonezawa K. The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog Mol Subcell Biol. 2001;26:115–154.
12. Lang F, Cohen P. Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms. Sci STKE. 2001;108:1–12.
13. Williams MR, Arthur JS, Balendran A, et al. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol. 2000;10:439–448.
14. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J. 2003;370:361–371.
15. Dittrich AC, Devarenne TP. Perspectives in PDK1 evolution: insights from photosynthetic and non-photosynthetic organisms. Plant Signal Behav. 2012;7:642–649.
16. Zaru R, Mollahan P, Watts C. 3-Phosphoinositide-dependent kinase 1 deficiency perturbs toll-like receptor signaling events and actin cytoskeleton dynamics in dendritic cells. J Biol Chem. 2008;283:929–939.
17. Jeong JJ, Kim B, Kim DH. Ginsenoside Rh1 eliminates the cytoprotective phenotype of human immunodeficiency virus type 1-transduced human macrophages by inhibiting the phosphorylation of pyruvate dehydrogenase lipoamide kinase isozyme 1. Biol Pharm Bull. 2013;36:1088–1094.
18. Kawano Y, Nakae J, Watanabe N, et al. Loss of Pdk1-Foxo1 signaling in myeloid cells predisposes to adipose tissue inflammation and insulin resistance. Diabetes. 2012;61:1935–1948.
19. Furundzija V, Fritzsche J, Kaufmann J, et al. IGF-1 increases macrophage motility via PKC/p38-dependent alphavbeta3-integrin inside-out signaling. Biochem Biophys Res Commun. 2010;394:786–791.
20. Hashimoto D, Chow A, Noizat C, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013;38:792–804.
21. Lee YG, Lee J, Byeon SE, et al. Functional role of Akt in macrophage-mediated innate immunity. Front Biosci. 2011;16:517–530.
22. Rigamonti E, Zordan P, Sciorati C, Rovere-Querini P, Brunelli S. Macrophage plasticity in skeletal muscle repair. Biomed Res Int. 2014;2014:1–9
23. Yu WG, He H, Yao JY, Zhu YX, Lu YH. Dimethyl cardamonin exhibits anti-inflammatory effects via interfering with the PI3K-PDK1-PKCalpha signaling pathway. Biomol Ther (Seoul). 2015;23:549–556.
24. Mosheimer BA, Kaneider NC, Feistritzer C, et al. Syndecan-1 is involved in osteoprotegerin-induced chemotaxis in human peripheral blood monocytes. J Clin Endocrinol Metab. 2005;90:2964–2971.
25. Chanput W, Mes JJ, Savelkoul HF, Wichers HJ. Characterization of polarized THP-1 macrophages and polarizing ability of LPS and food compounds. Food Funct. 2013;4:266–276.
26. Jin JH, Kim JS, Kang SS, Son KH, Chang HW, Kim HP. Anti-inflammatory and anti-arthritic activity of total flavonoids of the roots of Sophora flavescens. J Ethnopharmacol. 2010;127:589–595.
27. Lee YG, Lee WM, Kim JY, et al. Src kinase-targeted anti-inflammatory activity of davallialactone from Inonotus xeranticus in lipopolysaccharide-activated RAW264.7 cells. Br J Pharmacol. 2008;154:852–863.
28. Chazaud B, Brigitte M, Yacoub-Youssef H, et al. Dual and beneficial roles of macrophages during skeletal muscle regeneration. Exerc Sport Sci Rev. 2009;37:18–22.
29. Zajac E, Schweighofer B, Kupriyanova TA, et al. Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood. 2013;122:4054–4067.
30. Bueno-Silva B, Kawamoto D, Ando-Suguimoto ES, Alencar SM, Rosalen PL, Mayer MP. Brazilian red propolis attenuates inflammatory signaling cascade in LPS-activated macrophages. PLoS One. 2015;10:1–14.
31. Tang R, Zhang G, Chen SY. Response gene to complement 32 protein promotes macrophage phagocytosis via activation of protein kinase C pathway. J Biol Chem. 2014;289:22715–22722.
32. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol. 2001;19:275–290.
33. Laskin DL, Fakhrzadeh L, Heck DE, Gerecke D, Laskin JD. Upregulation of phosphoinositide 3-kinase and protein kinase B in alveolar macrophages following ozone inhalation. Role of NF-kappaB and STAT-1 in ozone-induced nitric oxide production and toxicity. Mol Cell Biochem. 2002;234-235:91–98.
34. Seo JW, Yang EJ, Yoo KH, Choi IH. Macrophage differentiation from monocytes is influenced by the lipid oxidation degree of low density lipoprotein. Mediators Inflamm. 2015;2015:1–10.
35. Utsugi M, Dobashi K, Ono A, et al. PI3K p110beta positively regulates lipopolysaccharide-induced IL-12 production in human macrophages and dendritic cells and JNK1 plays a novel role. J Immunol. 2009;182:5225–5231.
36. Kim BH, Lee YG, Lee J, Lee JY, Cho JY. Regulatory effect of cinnamaldehyde on monocyte/macrophage-mediated inflammatory responses. Mediators Inflamm. 2010;2010:1–9.
37. Xie S, Chen M, Yan B, He X, Chen X, Li D. Identification of a role for the PI3K/AKT/mTOR signaling pathway in innate immune cells. PLoS One. 2014;9:1–10.
38. Fan W, Morinaga H, Kim JJ, et al. FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. EMBO J. 2010;29:4223–4236.
39. Su D, Coudriet GM, Hyun Kim D, et al. FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages. Diabetes. 2009;58:2624–2633.
40. Martin M, Rehani K, Jope RS, Michalek SM. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol. 2005;6:777–784.
41. Woodgett JR, Ohashi PS. GSK3: an in-toll-erant protein kinase? Nat Immunol. 2005;6:751–752.
42. Hazeki K, Nigorikawa K, Hazeki O. Role of phosphoinositide 3-kinase in innate immunity. Biol Pharm Bull. 2007;30:1617–1623.
43. Tachado SD, Li X, Swan K, Patel N, Koziel H. Constitutive activation of phosphatidylinositol 3-kinase signaling pathway down-regulates TLR4-mediated tumor necrosis factor-alpha release in alveolar macrophages from asymptomatic HIV-positive persons in vitro. J Biol Chem. 2008;283:33191–33198.
44. Li H, Cheung W, Choo HH, Chan JH, Lai PS, Fred Wong WS. IL-10 synergistically enhances GM-CSF-induced CCR1 expression in myelomonocytic cells. Biochem Biophys Res Commun. 2003;304:417–424.
45. Hossen MJ, Cho JY, Kim D. PDK1 in NF-kappaB signaling is a target of Xanthium strumarium methanolic extract-mediated anti-inflammatory activities. J Ethnopharmacol. 2016;190:251–260.
46. Oh YJ, Youn JH, Min HJ, et al. CKD712, (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, inhibits the lipopolysaccharide-stimulated secretion of HMGB1 by inhibiting PI3K and classical protein kinase C. Int Immunopharmacol. 2011;11:1160–1165.
47. Robertson RC, Guiheneuf F, Bahar B, et al. The anti-inflammatory effect of algae-derived lipid extracts on lipopolysaccharide (LPS)-stimulated human THP-1 macrophages. Mar Drugs. 2015;13:5402–5424.
48. Yang WS, Lee BH, Kim SH, Kim HG, Yi YS, et al. Dipterocarpus tuberculatus ethanol extract strongly suppresses in vitro macrophage-mediated inflammatory responses and in vivo acute gastritis. J Ethnopharmacol. 2013;146:873–880.
49. Tan Z, Xie N, Cui H, et al. Pyruvate dehydrogenase kinase 1 participates in macrophage polarization via regulating glucose metabolism. J Immunol. 2015;194:6082–6089.
50. Al-Jarallah A, Chen X, Gonzalez L, Trigatti BL. High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists. PLoS One. 2014;9:1–14.
51. Fujisaka S, Usui I, Bukhari A, et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes. 2009;58:2574–2582.
52. Semba H, Takeda N, Isagawa T, et al. HIF-1alpha-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity. Nat Commun. 2016;7:1–10.
53. Meiser J, Kramer L, Sapcariu SC, et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J Biol Chem. 2016;291:3932–3946.
54. Lovewell RR, Hayes SM, O'Toole GA, Berwin B. Pseudomonas aeruginosa flagellar motility activates the phagocyte PI3K/Akt pathway to induce phagocytic engulfment. Am J Physiol Lung Cell Mol Physiol. 2014;306:L698–L707.
55. McGuire VA, Gray A, Monk CE, et al. Cross talk between the Akt and p38alpha pathways in macrophages downstream of toll-like receptor signaling. Mol Cell Biol. 2013;33:4152–4165.
56. Yoshida S, Gaeta I, Pacitto R, et al. Differential signaling during macropinocytosis in response to M-CSF and PMA in macrophages. Frontiers in physiology. 2015;6:1–9.
57. Raimondi C, Chikh A, Wheeler AP, Maffucci T, Falasca M. A novel regulatory mechanism links PLCgamma1 to PDK1. J Cell Sci. 2012;125:3153–3163.
58. Ganesan LP, Wei G, Pengal RA, et al. The serine/threonine kinase Akt promotes Fc gamma receptor-mediated phagocytosis in murine macrophages through the activation of p70S6 kinase. J Biol Chem. 2004;279:54416–54425.
59. Lu Y, Hu XB. C5a stimulates the proliferation of breast cancer cells via Akt-dependent RGC-32 gene activation. Oncol Rep. 2014;32:2817–2823.
60. Huang SC, Everts B, Ivanova Y, et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol. 2014;15:846–855.
61. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008;118:2992–3002.
62. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14:222–231.
63. Aroor AR, McKarns S, Demarco VG, Jia G, Sowers JR. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism: Clinical and Experimental. 2013;62:1543–1552.
64. Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation—mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol. 2012;32:1771–1776.
65. Zhao AZ, Shinohara MM, Huang D, et al. Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J Biol Chem. 2000;275:11348–11354.
66. Maya-Monteiro CM, Almeida PE, D'Avila H, et al. Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. J Biol Chem. 2008;283:2203–2210.
67. Maya-Monteiro CM, Bozza PT. Leptin and mTOR: partners in metabolism and inflammation. Cell Cycle. 2008;7:1713–1717.
68. He D, Wang H, Xu L, et al. Saikosaponin-a attenuates oxidized LDL uptake and prompts cholesterol efflux in THP-1 cells. J Cardiovasc Pharmacol. 2016;67:510–518.
69. Zhang Q, Sha Ma AZ, Wang C, Tang WQ, Song ZY. Nifedipine inhibits ox-LDL–induced lipid accumulation in human blood-derived macrophages. Biochem Biophys Res Commun. 2015;457:440–444.
70. Villalba M, Bi K, Hu J, et al. Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J Cell Biol. 2002;157:253–263.
71. Zheng H, Cui D, Quan X, et al. Lp-PLA2 silencing protects against ox-LDL-induced oxidative stress and cell apoptosis via Akt/mTOR signaling pathway in human THP1 macrophages. Biochem Biophys Res Commun. 2016;477:1017–1023.
72. Shapiro H, Lutaty A, Ariel A. Macrophages, meta-inflammation, and immuno-metabolism. ScientificWorldJournal. 2011;11:2509–2529.